In a recent exclusive interview with Famadillo.com, board-certified internist Dr. Jacob Teitelbaum revealed groundbreaking research findings that establish erectile dysfunction (ED) as a reliable risk factor for undiagnosed prediabetes and type 2 diabetes in young men aged 18 to 40. The study, published in the September issue of Preventive Medicine, emphasizes ED as a consistent marker for these conditions, with low testosterone identified as a common underlying biochemical factor.
Louisa Ora: How does one differentiate diabetes from regular ED?
Dr. Teitelbaum: “Erectile dysfunction (ED) simply refers to an inability to get and sustain an erection as needed for intercourse. Although diabetes often causes ED, it is only one of numerous triggers.”
Louisa Ora: Where is the line between psychological ED versus something more?
Dr. Teitelbaum: “Psychological causes of ED should be considered if a man often wakes up with a normal erection but experiences erectile problems only during intercourse.”
Louisa Ora: What are the warning signs of diabetes ED?
Dr. Teitelbaum: “Warning signs of diabetes include increased thirst and urination. Diabetes is part of the same process that often causes high blood pressure and high cholesterol, known as metabolic syndrome or insulin resistance. If one of these is present, all three should be checked.”
“For erectile dysfunction (ED), there is no need to look for warning signs. Just be aware that treatment is available if ED symptoms are present.”
Louisa Ora: Should we be concerned as a society?
Dr. Teitelbaum: “Absolutely not. Despite the increase in media reporting supporting fear and divisiveness about many things, the world is actually a fairly wonderful place. The ability to take measures to prevent or address both ED and diabetes effectively is increasing. There is an excellent reason for optimism.”
The recent study concluded that clinicians should view ED as a telltale risk factor for prediabetes and type 2 diabetes. It suggested routine testing for early-onset hyperglycemia in ED patients.
Dr. Teitelbaum highlighted a critical gap in identifying low testosterone in blood work. He explained that defining the ‘normal’ testosterone range too broadly leads to untreated patients who may develop full-blown type 2 diabetes over time. Simple and low-cost treatments, such as clomiphene, could stimulate a man’s own healthy testosterone production.
The study offers promising avenues for treatment, including lifestyle changes and targeted herbals like berberine and hintonia latiflora. However, Dr. Teitelbaum emphasized that this valuable information might not reach physicians easily due to funding constraints. As a result, individuals are urged to take proactive steps by sharing the study with their healthcare providers.
This new research not only sheds light on the connections between ED and diabetes but also underscores the importance of early detection and intervention for better overall health.